Companion Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1062789
  • May 2021
  • Biotechnology
  • 136 Pages
The global Companion Diagnostics market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Companion Diagnostics market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Companion Diagnostics market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Companion Diagnostics market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Abbott Laboratories Molecular, Inc., Agilent (Dako Denmark A/S), ARUP Laboratories, BioMerieux SA, Danaher Corporation (Leica Microsystems), Foundation Medicine, Inc., Myriad Genetics, Inc., Qiagen N.V., Roche (Ventana Medical Systems, Inc.), Thermo Fisher Scientific (Life Technologies Corporation)
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Companion Diagnostics market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Companion Diagnostics market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Companion Diagnostics market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Companion Diagnostics market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Companion Diagnostics Market:
The Companion Diagnostics market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Abbott Laboratories Molecular, Inc., Agilent (Dako Denmark A/S), ARUP Laboratories, BioMerieux SA, Danaher Corporation (Leica Microsystems), Foundation Medicine, Inc., Myriad Genetics, Inc., Qiagen N.V., Roche (Ventana Medical Systems, Inc.), Thermo Fisher Scientific (Life Technologies Corporation)

Companion Diagnostics Market Segment Analysis:
by Technology Type
Immunohistochemistry
Polymerase Chain Reaction [PCR]
Next Generation Sequencing [NGS]
In Situ Hybridization
Others
Indication
Oncology
Neurology
Others

Geographic Coverage for Companion Diagnostics Market:
The market research report on global Companion Diagnostics market offers complete analysis across various regions across the world. The Companion Diagnostics market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Companion Diagnostics market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Companion Diagnostics Market Value and Forecast
  • US
  • Canada
Europe Companion Diagnostics Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Companion Diagnostics Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Companion Diagnostics Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Companion Diagnostics Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Companion Diagnostics market report:
  • The report provides key trends of the global Companion Diagnostics market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Companion Diagnostics industry
  • The report covers all the recent developments of the Companion Diagnostics market and helps to provide current industry updates
  • The report covers a detailed look over the global Companion Diagnostics Industry and provides with significant actionable insights
  • The Companion Diagnostics market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Companion Diagnostics market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Companion Diagnostics market
  • Comprehensive analysis of the Companion Diagnostics market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Companion Diagnostics market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Companion Diagnostics market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Companion Diagnostics market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Companion Diagnostics market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Companion Diagnostics market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Abbott Laboratories Molecular, Inc.
  • Agilent (Dako Denmark A/S)
  • ARUP Laboratories
  • BioMerieux SA
  • Danaher Corporation (Leica Microsystems)
  • Foundation Medicine, Inc.
  • Myriad Genetics, Inc.
  • Qiagen N.V.
  • Roche (Ventana Medical Systems, Inc.)
  • Thermo Fisher Scientific (Life Technologies Corporation)
  • Immunohistochemistry
  • Polymerase Chain Reaction [PCR]
  • Next Generation Sequencing [NGS]
  • In Situ Hybridization
  • Others
  • Oncology
  • Neurology
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Companion Diagnostics Market Snapshot
          2.1.1. Global Companion Diagnostics Market By Technology Type,2019
               2.1.1.1.Immunohistochemistry
               2.1.1.2.Polymerase Chain Reaction [PCR]
               2.1.1.3.Next Generation Sequencing [NGS]
               2.1.1.4.In Situ Hybridization
               2.1.1.5.Others
          2.1.2. Global Companion Diagnostics Market By Indication,2019
               2.1.2.1.Oncology
               2.1.2.2.Neurology
               2.1.2.3.Others
          2.1.3. Global Companion Diagnostics Market By End-use,2019
          2.1.4. Global Companion Diagnostics Market By Geography,2019

3. Global Companion Diagnostics Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Companion Diagnostics Market Size (US$), By Technology Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Technology Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Technology Type, 2020
     4.2. Global Companion Diagnostics Market Size (US$), By Technology Type, 2018 – 2028

5. Global Companion Diagnostics Market Size (US$), By Indication, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Indication, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Indication, 2020
     5.2. Global Companion Diagnostics Market Size (US$), By Indication, 2018 – 2028

6. Global Companion Diagnostics Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Companion Diagnostics Market Size (US$), By End-use, 2018 – 2028

7. Global Companion Diagnostics Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Companion Diagnostics Market Analysis, 2018 – 2028 
          7.2.1. North America Companion Diagnostics Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Companion Diagnostics Market Size (US$), By Technology Type, 2018 – 2028
          7.2.3. North America Companion Diagnostics Market Size (US$), By Indication, 2018 – 2028
          7.2.4. North America Companion Diagnostics Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Companion Diagnostics Market Analysis, 2018 – 2028 
          7.3.1.  Europe Companion Diagnostics Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Companion Diagnostics Market Size (US$), By Technology Type, 2018 – 2028
          7.3.3. Europe Companion Diagnostics Market Size (US$), By Indication, 2018 – 2028
          7.3.4. Europe Companion Diagnostics Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Companion Diagnostics Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Companion Diagnostics Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Companion Diagnostics Market Size (US$), By Technology Type, 2018 – 2028
          7.4.3. Asia Pacific Companion Diagnostics Market Size (US$), By Indication, 2018 – 2028
          7.4.4. Asia Pacific Companion Diagnostics Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Companion Diagnostics Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Companion Diagnostics Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Companion Diagnostics Market Size (US$), By Technology Type, 2018 – 2028
          7.5.3. Latin America Companion Diagnostics Market Size (US$), By Indication, 2018 – 2028
          7.5.4. Latin America Companion Diagnostics Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Companion Diagnostics Market Analysis, 2018 – 2028 
          7.6.1.  MEA Companion Diagnostics Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Companion Diagnostics Market Size (US$), By Technology Type, 2018 – 2028
          7.6.3. MEA Companion Diagnostics Market Size (US$), By Indication, 2018 – 2028
          7.6.4. MEA Companion Diagnostics Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Companion Diagnostics Providers
        8.4.1 Abbott Laboratories Molecular, Inc.
                8.4.1.1 Business Description
                8.4.1.2 Abbott Laboratories Molecular, Inc. Geographic Operations
                8.4.1.3 Abbott Laboratories Molecular, Inc. Financial Information
                8.4.1.4 Abbott Laboratories Molecular, Inc. Product Positions/Portfolio
                8.4.1.5 Abbott Laboratories Molecular, Inc. Key Developments
        8.4.2 Agilent (Dako Denmark A/S)
                8.4.2.1 Business Description
                8.4.2.2 Agilent (Dako Denmark A/S) Geographic Operations
                8.4.2.3 Agilent (Dako Denmark A/S) Financial Information
                8.4.2.4 Agilent (Dako Denmark A/S) Product Positions/Portfolio
                8.4.2.5 Agilent (Dako Denmark A/S) Key Developments
        8.4.3 ARUP Laboratories
                8.4.3.1 Business Description
                8.4.3.2 ARUP Laboratories Geographic Operations
                8.4.3.3 ARUP Laboratories Financial Information
                8.4.3.4 ARUP Laboratories Product Positions/Portfolio
                8.4.3.5 ARUP Laboratories Key Developments
        8.4.4 BioMerieux SA
                8.4.4.1 Business Description
                8.4.4.2 BioMerieux SA Geographic Operations
                8.4.4.3 BioMerieux SA Financial Information
                8.4.4.4 BioMerieux SA Product Positions/Portfolio
                8.4.4.5 BioMerieux SA Key Developments
        8.4.5 Danaher Corporation (Leica Microsystems)
                8.4.5.1 Business Description
                8.4.5.2 Danaher Corporation (Leica Microsystems) Geographic Operations
                8.4.5.3 Danaher Corporation (Leica Microsystems) Financial Information
                8.4.5.4 Danaher Corporation (Leica Microsystems) Product Positions/Portfolio
                8.4.5.5 Danaher Corporation (Leica Microsystems) Key Developments
        8.4.6 Foundation Medicine, Inc.
                8.4.6.1 Business Description
                8.4.6.2 Foundation Medicine, Inc. Geographic Operations
                8.4.6.3 Foundation Medicine, Inc. Financial Information
                8.4.6.4 Foundation Medicine, Inc. Product Positions/Portfolio
                8.4.6.5 Foundation Medicine, Inc. Key Developments
        8.4.7 Myriad Genetics, Inc.
                8.4.7.1 Business Description
                8.4.7.2 Myriad Genetics, Inc. Geographic Operations
                8.4.7.3 Myriad Genetics, Inc. Financial Information
                8.4.7.4 Myriad Genetics, Inc. Product Positions/Portfolio
                8.4.7.5 Myriad Genetics, Inc. Key Developments
        8.4.8 Qiagen N.V.
                8.4.8.1 Business Description
                8.4.8.2 Qiagen N.V. Geographic Operations
                8.4.8.3 Qiagen N.V. Financial Information
                8.4.8.4 Qiagen N.V. Product Positions/Portfolio
                8.4.8.5 Qiagen N.V. Key Developments
        8.4.9 Roche (Ventana Medical Systems, Inc.)
                8.4.9.1 Business Description
                8.4.9.2 Roche (Ventana Medical Systems, Inc.) Geographic Operations
                8.4.9.3 Roche (Ventana Medical Systems, Inc.) Financial Information
                8.4.9.4 Roche (Ventana Medical Systems, Inc.) Product Positions/Portfolio
                8.4.9.5 Roche (Ventana Medical Systems, Inc.) Key Developments
        8.4.10 Thermo Fisher Scientific (Life Technologies Corporation)
                8.4.10.1 Business Description
                8.4.10.2 Thermo Fisher Scientific (Life Technologies Corporation) Geographic Operations
                8.4.10.3 Thermo Fisher Scientific (Life Technologies Corporation) Financial Information
                8.4.10.4 Thermo Fisher Scientific (Life Technologies Corporation) Product Positions/Portfolio
                8.4.10.5 Thermo Fisher Scientific (Life Technologies Corporation) Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Companion Diagnostics Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Companion Diagnostics Market Revenue, By Technology Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Companion Diagnostics Market Revenue, By Indication, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Companion Diagnostics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Companion Diagnostics Market Revenue, By Technology Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Companion Diagnostics Market Revenue, By Indication, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Companion Diagnostics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Companion Diagnostics Market Revenue, By Technology Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Companion Diagnostics Market Revenue, By Indication, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Companion Diagnostics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Companion Diagnostics Market Revenue, By Technology Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Companion Diagnostics Market Revenue, By Indication, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Companion Diagnostics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Companion Diagnostics Market Revenue, By Technology Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Companion Diagnostics Market Revenue, By Indication, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Companion Diagnostics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Companion Diagnostics: Market Segmentation 
FIG. 2 Global Companion Diagnostics Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Companion Diagnostics Market, By Technology Type, 2019 (US$ Mn) 
FIG. 5 Global Companion Diagnostics Market, By Indication, 2019 (US$ Mn) 
FIG. 6 Global Companion Diagnostics Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Companion Diagnostics Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Companion Diagnostics Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Companion Diagnostics Providers, 2019
FIG. 11 Global Companion Diagnostics Market Revenue Contribution, By Technology Type, 2019 & 2028 (Value %) 
FIG. 12 Global Companion Diagnostics Market Revenue Contribution, By Indication, 2019 & 2028 (Value %) 
FIG. 13 Global Companion Diagnostics Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Companion Diagnostics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Companion Diagnostics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Companion Diagnostics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Companion Diagnostics Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Companion Diagnostics Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Companion Diagnostics market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Companion Diagnostics Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Companion Diagnostics Market Value, By Segment1, 2018 – 2028
TABLE  North America Companion Diagnostics Market Value, By Segment2, 2018 – 2028
TABLE  North America Companion Diagnostics Market Value, By Country, 2018 – 2028
TABLE  Europe Companion Diagnostics Market Value, By Segment1, 2018 – 2028
TABLE  Europe Companion Diagnostics Market Value, By Segment2, 2018 – 2028
TABLE  Europe Companion Diagnostics Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Companion Diagnostics Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Companion Diagnostics Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Companion Diagnostics Market Value, By Country, 2018 – 2028
TABLE  Latin America Companion Diagnostics Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Companion Diagnostics Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Companion Diagnostics Market Value, By Country, 2018 – 2028
TABLE  MEA Companion Diagnostics Market Value, By Segment1, 2018 – 2028
TABLE  MEA Companion Diagnostics Market Value, By Segment2, 2018 – 2028
TABLE  MEA Companion Diagnostics Market Value, By Country, 2018 – 2028
TABLE  Abbott Laboratories Molecular, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Agilent (Dako Denmark A/S): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ARUP Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  BioMerieux SA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Danaher Corporation (Leica Microsystems): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Foundation Medicine, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Myriad Genetics, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Qiagen N.V.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Roche (Ventana Medical Systems, Inc.): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Thermo Fisher Scientific (Life Technologies Corporation): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Companion Diagnostics Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Companion Diagnostics Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Companion Diagnostics Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Companion Diagnostics Market, By Geography, 2019 (US$ Mn)
FIG.  Global Companion Diagnostics Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Companion Diagnostics Providers, 2016
FIG.  Global Companion Diagnostics Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Polymerase Chain Reaction [PCR] Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Next Generation Sequencing [NGS] Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global In Situ Hybridization Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Companion Diagnostics Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Neurology Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Companion Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Companion Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Companion Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Companion Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Companion Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Companion Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Companion Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Companion Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Companion Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Companion Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Companion Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Companion Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Companion Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Companion Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Companion Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Companion Diagnostics Market Value, 2018 – 2028, (US$ Mn)